p38 mitogen-activated protein kinase inhibitors for the treatment of chronic cardiovascular disease.

Behr, Thomas M; Berova, Marinela; Doe, Christopher P; Ju, Haisong; Angermann, Christiane E; Boehm, Jeffrey; Willette, Robert N

Behr, Thomas M; Berova, Marinela; Doe, Christopher P; Ju, Haisong; Angermann, Christiane E; Boehm, Jeffrey; Willette, Robert N.

Affiliation

Behr TM; Medizinische Poliklinik, Department of Cardiology, University of Wuerzburg, Klinikstrasse 6-8, 97070 Wuerzburg, Germany. Behr_T@medizin.uni-wuerzburg.de

Curr Opin Investig Drugs ; 4(9): 1059-64, 2003 Sep.

Article in En | MEDLINE | ID: mdl-14582449

Subject(s)

Cardiovascular Diseases/drug therapy; Enzyme Inhibitors/therapeutic use; Mitogen-Activated Protein Kinases/antagonists & inhibitors; Animals; Cardiovascular Diseases/enzymology; Chronic Disease; Clinical Trials as Topic; Enzyme Inhibitors/chemistry; Heart/drug effects; Humans; Molecular Structure; Myocardium/enzymology; p38 Mitogen-Activated Protein Kinases

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Mitogen-Activated Protein Kinases / Enzyme Inhibitors Limits: Animals / Humans Language: En Journal: Curr Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2003 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links